Cortical sporadic Creutzfeldt-Jakob Disease (Q85595): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/1724965250 / rank | |||
Normal rank | |||
Revision as of 10:57, 15 August 2026
Cortical sporadic Creutzfeldt-Jakob disease (sCJD) is predominantly characterised by dementia. The accumulated prion protein is MM2 (MM2-cortical) and VV1 which means there is a type 1 abnormal prion protein with valine homozygote at codon 129 polymorphic site of prion protein gene. Ataxic sCJD is characterised by predominant ataxia and accumulation of MV2 or VV2.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1724965250 |
||
| English | Cortical sporadic Creutzfeldt-Jakob Disease |
Cortical sporadic Creutzfeldt-Jakob disease (sCJD) is predominantly characterised by dementia. The accumulated prion protein is MM2 (MM2-cortical) and VV1 which means there is a type 1 abnormal prion protein with valine homozygote at codon 129 polymorphic site of prion protein gene. Ataxic sCJD is characterised by predominant ataxia and accumulation of MV2 or VV2. |
